Cargando…
Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky
INTRODUCTION: High-risk human epidermal growth factor receptor 2 (HER2)-positive adenocarcinomas associate with early recurrence and death, prompting consideration of novel radiotherapeutic options like a trastuzumab-linked thorium-227 alpha-particle emitting radionuclide. METHODS: We conducted a re...
Autores principales: | Kunos, Charles A., Fabian, Denise, Piecoro, Dava W., Napier, Dana, Miller, Rachel W., Ueland, Frederick R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902924/ https://www.ncbi.nlm.nih.gov/pubmed/36761943 http://dx.doi.org/10.3389/fonc.2023.948348 |
Ejemplares similares
-
Characterization of Uterine Cervix Cancers in Women from Appalachian Kentucky
por: Kunos, Charles A., et al.
Publicado: (2021) -
Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer
por: Kunos, Charles A., et al.
Publicado: (2023) -
Human gastrin- releasing peptide receptor expression in women with uterine cervix cancer
por: Kunos, Charles A., et al.
Publicado: (2023) -
Experiencing Cancer in Appalachian Kentucky
por: McComsey, Melanie, et al.
Publicado: (2020) -
Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer
por: Kunos, Charles A., et al.
Publicado: (2019)